Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,792 | -96,692 | -62,866 | -123,737 | -63,866 |
| Depreciation Amortization | 2,541 | 14,741 | 12,081 | 8,287 | 4,033 |
| Accounts receivable | 151 | 10,664 | 12,364 | 11,564 | 14,113 |
| Accounts payable and accrued liabilities | 6,492 | 2,074 | 5,729 | 3,221 | 4,117 |
| Other Working Capital | 23,107 | -37,616 | 34,856 | 11,404 | 19,925 |
| Other Operating Activity | 11,035 | 26,415 | -2,177 | -3,828 | -12,888 |
| Operating Cash Flow | $-52,466 | $-80,414 | $-13 | $-93,089 | $-34,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -985 | -9,676 | -7,283 | -6,344 | -4,089 |
| Purchase Of Investment | N/A | -404,425 | -314,439 | -121,135 | -75,857 |
| Sale Of Investment | 49,195 | 385,292 | 269,935 | 156,381 | 66,876 |
| Investing Cash Flow | $48,210 | $-28,809 | $-51,787 | $28,902 | $-13,070 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -5,131 | -2,159 | -1,369 | -613 |
| Common Stock Issued | 34,352 | 59,522 | 32,275 | 22,016 | 11,792 |
| Financing Cash Flow | $34,352 | $54,391 | $30,116 | $20,647 | $11,179 |
| Exchange Rate Effect | -53 | -46 | 11 | 49 | 297 |
| Beginning Cash Position | 4,762 | 59,640 | 59,640 | 59,640 | 59,640 |
| End Cash Position | 34,805 | 4,762 | 37,967 | 16,149 | 23,480 |
| Net Cash Flow | $30,043 | $-54,878 | $-21,673 | $-43,491 | $-36,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,466 | -80,414 | -13 | -93,089 | -34,566 |
| Capital Expenditure | -985 | -9,676 | -7,283 | -6,344 | -4,089 |
| Free Cash Flow | -53,451 | -90,090 | -7,296 | -99,433 | -38,655 |